Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004227787 | SCV003741851 | pathogenic | Cardiovascular phenotype | 2021-08-02 | criteria provided, single submitter | clinical testing | The c.8607delT (p.F2869Lfs*40) alteration, located in exon 25 (coding exon 24) of the TNXB gene, consists of a deletion of one nucleotide at position 8607, causing a translational frameshift with a predicted alternate stop codon after 40 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |
Fulgent Genetics, |
RCV005047385 | SCV005669494 | likely pathogenic | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2024-03-28 | criteria provided, single submitter | clinical testing |